Plus Therapeutics company info

What does Plus Therapeutics do?
Plus Therapeutics (NASDAQ:PSTV) is a clinical-stage pharmaceutical company focused on the development of innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers. Their work centers around harnessing the power of radiation therapy in new, minimally invasive ways to provide better treatment options for patients with cancer. Plus Therapeutics is actively advancing a portfolio of promising drug candidates through clinical trials, aiming to address the unmet medical needs of patients suffering from cancers that currently have limited treatment options. Their objective is to significantly improve outcomes and the quality of life for cancer patients by bringing breakthrough therapies to market.
Plus Therapeutics company media
Company Snapshot

Is Plus Therapeutics a public or private company?


How many people does Plus Therapeutics employ?


What sector is Plus Therapeutics in?

pie chart
Health Care

Where is the head office for Plus Therapeutics?

location pin
Head Office
Austin, United States

What year was Plus Therapeutics founded?

founded flag
Year Founded
What does Plus Therapeutics specialise in?
/Cancer Therapies /Nanotechnology Drugs /Radiotherapeutic Agents /Drug Development /Precision Oncology /Clinical Stage

What are the products and/or services of Plus Therapeutics?

Overview of Plus Therapeutics offerings
DocePLUS, a liposomal formulation of the chemotherapy drug docetaxel, designed to enhance effectiveness and reduce toxicity.
An autologous cell therapy program focused on regenerative medicine, utilizing patients' own cells to treat various diseases.
Development of a proprietary nanotechnology platform for targeted delivery of therapeutic agents, aimed at improving the precision and efficacy of cancer treatments.
Partnerships and licensing agreements aimed at leveraging their nanotechnology platform for the development and delivery of innovative therapeutics.

Who is in the executive team of Plus Therapeutics?

Plus Therapeutics leadership team
  • Dr. Marc H. Hedrick M.B.A., M.D.
    Dr. Marc H. Hedrick M.B.A., M.D.
    President, CEO & Director
  • Mr. Andrew J. Sims CPA
    Mr. Andrew J. Sims CPA
    VP of Finance & CFO
  • Dr. Norman D.  LaFrance FACNP, FACP, M.D.
    Dr. Norman D. LaFrance FACNP, FACP, M.D.
    Chief Medical Officer & Senior VP
  • Ms. Desiree  Smith
    Ms. Desiree Smith
    Corporate Controller, Principal Financial & Accounting Officer
  • Dr. John K. Fraser
    Dr. John K. Fraser
    Chief Scientist